{"title":"Peut-on valoriser la viande de sanglier excédentaire en tant que source alimentaire ?","authors":"Jeanne Brugère-Picoux , Pascale Gilli-Dunoyer , Catherine Magras","doi":"10.1016/j.banm.2026.01.020","DOIUrl":"10.1016/j.banm.2026.01.020","url":null,"abstract":"<div><div>The overpopulation of wild boar in France is accompanied by damage to agricultural and forest areas, impacts on road safety and the railway network, the colonization of new areas (including urban areas), and an increased risk of epizootics and/or zoonoses that can harm pig farming. Hunting, the only solution for regulating game populations, must be accompanied by the promotion of wild boar meat, a source of high-quality food raw material with controlled risks. Besides domestic or private use by hunters, who are the main consumers, wild boar carcasses from hunting can be offered to consumers through two types of distribution channels: either short (via retail outlets) or long (after passing through a collection center, a processing plant, and then a retail outlet or restaurant). This article presents a project for a sector to be organized, transforming a French raw material (wild boar hunted) into ready-to-eat meat, available in all seasons. The meat, sold in smaller units, will be pre-cooked using slow cooking methods, adhering to new culinary preparation techniques (according to a “best practices guide”) and guaranteeing tenderness, before being sold frozen. The distribution of larger quantity of wild boar meat through commercial channels represents a sociological revolution, as historically, the “game meat” industry was not designed for mass consumption.</div></div>","PeriodicalId":55317,"journal":{"name":"Bulletin De L Academie Nationale De Medecine","volume":"210 4","pages":"Pages 453-460"},"PeriodicalIF":0.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147756468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Hypertension intracrânienne idiopathique, la malnommée – un concept évolutif","authors":"Lou Grangeon , Cédric Gollion , Caroline Roos , Anne Ducros","doi":"10.1016/j.banm.2026.01.015","DOIUrl":"10.1016/j.banm.2026.01.015","url":null,"abstract":"<div><div>Idiopathic intracranial hypertension (IIH), long referred to as pseudotumor cerebri or “benign intracranial hypertension”, illustrates the evolution of a concept long defined by the exclusion of identifiable causes into a distinct entity with a well-recognized venous mechanism. Far from benign, this condition primarily affects overweight young women and represents a major cause of preventable blindness. Recent advances in neuroimaging, particularly magnetic resonance venography, have revealed bilateral transverse sinus stenoses in more than 90% of patients. This discovery has significantly improved the understanding of IIH pathophysiology and opened new therapeutic perspectives. Current management relies primarily on weight reduction, the only proven aetiologic treatment, and on acetazolamide, which decreases cerebrospinal fluid (CSF) production. In cases of medical failure or visual threat, traditional neurosurgical techniques (such as ventriculo-peritoneal shunting and optic nerve sheath fenestration) remain effective but are associated with high revision rates. Over the past two decades, transverse venous sinus stenting has emerged as a causal therapeutic approach aimed at restoring venous outflow. Large retrospective series have reported more than 80% clinical improvement, normalization of the trans-stenotic pressure gradient, and less than 2% of major complications. Three randomized controlled trials: DIVE-IIN EARLY and DIVE-IIN LATE (both led in France) and IIH Intervention (United Kingdom), are currently underway to define the exact role of venous stenting within the therapeutic algorithm of IIH. The results of these studies are expected to mark a major turning point in the future management of this condition, long regarded as “idiopathic”.</div></div>","PeriodicalId":55317,"journal":{"name":"Bulletin De L Academie Nationale De Medecine","volume":"210 4","pages":"Pages 481-487"},"PeriodicalIF":0.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147756474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Discussion à propos de la communication : « Lésions focales du cartilage articulaire : possibilités thérapeutiques actuelles et perspectives »","authors":"Didier Mainard","doi":"10.1016/j.banm.2026.03.002","DOIUrl":"10.1016/j.banm.2026.03.002","url":null,"abstract":"","PeriodicalId":55317,"journal":{"name":"Bulletin De L Academie Nationale De Medecine","volume":"210 4","pages":"Pages 521-522"},"PeriodicalIF":0.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147756587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Évolution des sources alimentaires en nutrition humaine","authors":"Jean Derégnaucourt , Jean-Noel Fiessinger","doi":"10.1016/j.banm.2026.03.001","DOIUrl":"10.1016/j.banm.2026.03.001","url":null,"abstract":"","PeriodicalId":55317,"journal":{"name":"Bulletin De L Academie Nationale De Medecine","volume":"210 4","pages":"Pages 399-400"},"PeriodicalIF":0.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147756663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Communiqué. Le don d’organes : une priorité vitale pour la santé publique","authors":"Académie nationale de médecine","doi":"10.1016/j.banm.2026.03.012","DOIUrl":"10.1016/j.banm.2026.03.012","url":null,"abstract":"","PeriodicalId":55317,"journal":{"name":"Bulletin De L Academie Nationale De Medecine","volume":"210 4","pages":"Page 398"},"PeriodicalIF":0.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147756916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Communiqué. L’ANM soutient la déclaration de l’Institut Pasteur face aux attaques de l’administration américaine contre la médecine","authors":"Académie nationale de médecine","doi":"10.1016/j.banm.2026.03.008","DOIUrl":"10.1016/j.banm.2026.03.008","url":null,"abstract":"","PeriodicalId":55317,"journal":{"name":"Bulletin De L Academie Nationale De Medecine","volume":"210 4","pages":"Page 394"},"PeriodicalIF":0.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147756462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Sources de protéines animales et végétales en santé humaine","authors":"François Mariotti","doi":"10.1016/j.banm.2025.12.029","DOIUrl":"10.1016/j.banm.2025.12.029","url":null,"abstract":"<div><div>This review provides an integrative analysis of the relationship between animal and plant protein sources and human health, combining several complementary methodological approaches. The analysis at different levels ranges from fundamental metabolic mechanisms related to amino acids, to the long-term epidemiological impacts of dietary protein profiles, including interventional nutritional studies. The relationships between animal and plant protein intake and protein metabolism, particularly in the postprandial anabolic phase, highlight differences between proteins taken in isolation, but the repercussions on medium-term metabolism, muscle function, or the risk of sarcopenia are not well documented. On the other hand, data from randomised controlled trials combined with the results of large observational cohorts establish strong links between plant protein consumption and reduced cardiometabolic risk. Substitution modelling approaches point in particular to the long-term health benefits of replacing certain animal protein sources such as red meat and charcuterie with certain plant protein sources such as legumes. Analysis of the ‘protein package’ sheds light on the mechanisms underlying the observed effects and associations, demonstrating the importance of plant protein sources that provide beneficial nutrients and bioactive compounds. We conclude that the issue of protein sources should not be reduced to a binary consideration of animal and plant sources, but should be addressed in detail at the level of protein sources and dietary patterns, taking an integrative approach. From a global perspective, the future also lies in integrating the other dimensions of sustainability.</div></div>","PeriodicalId":55317,"journal":{"name":"Bulletin De L Academie Nationale De Medecine","volume":"210 4","pages":"Pages 434-442"},"PeriodicalIF":0.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147756467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Sécurité et qualité des aliments en Europe : tout ne peut pas être fait ou se dire hors du cadre réglementaire","authors":"Catherine Magras","doi":"10.1016/j.banm.2025.11.010","DOIUrl":"10.1016/j.banm.2025.11.010","url":null,"abstract":"<div><div>With the constant identification of nutrient sources, new types of food are being proposed for human (and animal) diets. Nevertheless, in France as in the European Union, from the moment they are first placed on the market, foodstuffs (products) must comply with current regulations on health and safety, fair trading, consumer protection and the protection of food-producing animals. The regulatory classification of a food or “novel food” is therefore decisive for its authorization, production and marketing. Several examples, including edible insects, will illustrate the main foundations of food legislation and its requirements in terms of human health.</div></div>","PeriodicalId":55317,"journal":{"name":"Bulletin De L Academie Nationale De Medecine","volume":"210 4","pages":"Pages 401-409"},"PeriodicalIF":0.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147756664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Marie-Paule Vazquez , Martine Bagot , Catherine Adamsbaum, Didier Lacombe, Antoine Petit , François Richard, Sylvain Rigal, groupe de travail des Commissions 8 et 9 de l’Académie nationale de médecine
{"title":"Rapport 26-03. Photographie et vidéo médicales, éléments essentiels du dossier médical, des soins, de l’enseignement et de la recherche","authors":"Marie-Paule Vazquez , Martine Bagot , Catherine Adamsbaum, Didier Lacombe, Antoine Petit , François Richard, Sylvain Rigal, groupe de travail des Commissions 8 et 9 de l’Académie nationale de médecine","doi":"10.1016/j.banm.2026.03.006","DOIUrl":"10.1016/j.banm.2026.03.006","url":null,"abstract":"<div><div>Medical and video photography (PVM) is by definition “the capture of images of the body envelope, accessible natural cavities or wounds either from trauma or surgery, without interposed device”. It is not registered as such in the institutional lists describing medical records. However, it has become indispensable daily and is recommended in many medical specialties. It is an essential tool for diagnosis, monitoring, coordination of care, remote opinions and medico-legal documentation. The report aims to clarify the status of PVM, its organization, uses and security. It details its uses both in public hospitals, and private structures and practice. The sources used include institutional recommendations (scientific societies, HAS, technical sheets of the Common Classification of Medical Acts), and practices outlined in various specialties. There is a great deal of organizational heterogeneity linked to the lack of photographic laboratories, the scarcity of medical photographers and/or dedicated people, the massive use of smartphones, the dispersion of data, and insufficient integration into the patient digital file. The solutions, which depend on the volume of images and care protocols, are based on dedicated cameras, equipped laboratories, trained referents including a possible medical photographer, integration into the hospital information system, and secure dedicated applications. PVM must be recognized as specific medical data, subject to the same rules as other health data (General Data Protection Regulations [GDPR], the Data Protection Act [DPA], medical confidentiality, storage and patient access). Securing and promoting PVM requires strong commitment from institutions and their management to guarantee quality, traceability, certified storage, access and regulatory compliance. In private practice, the same quality and security requirements apply, although the organizational means differ. It is essential to improve dedicated human and technical resources, formal recognition in medical records, financial valuation, and harmonization between the public and private sectors. The educational value of PVM is recognized, but its use for teaching and research requires specific written consent and anonymization procedures. These elements underline the urgency of a coordinated institutional response, articulated around institutional management and national authorities. Seven recommendations are formulated: 1. Official recognition in medical records. 2. Application of the common legal framework to digital health data. 3. Appropriate human and technical resources. 4. Institutional valorisation. 5. Official recognition of the profession of medical photographer. 6. Initial and continuous training for medical doctors and odontologists. 7. Supervision of use in teaching and research.</div></div>","PeriodicalId":55317,"journal":{"name":"Bulletin De L Academie Nationale De Medecine","volume":"210 4","pages":"Pages 386-393"},"PeriodicalIF":0.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147756461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Physiopathologie de la migraine","authors":"Cédric Gollion , Lou Grangeon , Caroline Roos , Anne Ducros","doi":"10.1016/j.banm.2026.01.019","DOIUrl":"10.1016/j.banm.2026.01.019","url":null,"abstract":"<div><div>Migraine is a common and disabling neurological disorder underpinned by a complex pathophysiology involving multiple interactions between the peripheral and central nervous systems, vascular structures, and specific molecular pathways. Far from being a simple headache, it results from a multifaceted cascade of neurobiological events that remain only partially understood. This review aims to present recent advances in the understanding of migraine mechanisms, encompassing neurovascular neurotransmitters, hypothalamic circuits, and cortical phenomena. Discovery of the crucial role of calcitonin gene-related peptide (CGRP) in migraine headache has led to the development of highly effective targeted therapies. Understanding how a migraine attack unfolds is essential not only to improving its management but also to appreciating why migraine remains one of the major challenges in modern neurology.</div></div>","PeriodicalId":55317,"journal":{"name":"Bulletin De L Academie Nationale De Medecine","volume":"210 4","pages":"Pages 461-467"},"PeriodicalIF":0.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147756470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}